Breast Cancer Update Home - Oncology Leader Commentary

Home: Oncology Leader Commentary: Sir Richard Peto, MD

Click on the topic below for comments by Dr Richard Peto to comment on. You will also find links to related articles and clinical trials.

2000 meta-analysis
Tamoxifen in younger women
Tamoxifen plus chemotherapy
Tamoxifen and second cancers
Tamoxifen in ER-negative patients
Duration of tamoxifen
ATLAS trial; Adjuvant Tamoxifen Longer Against Shorter
Breast cancer recurrence in the second decade after diagnosis
Declining breast cancer mortality rates
Effects of local therapy on breast cancer mortality

Home

Patrick I. Borgen, MD

Aman Buzdar, MD

Nancy E. Davidson, MD

J. Michael Dixon, MD

Armando Giuliano, MD

I. Craig Henderson, MD

David Krag, MD

Gershon Locker, MD

Charles Loprinzi, MD

Richard Margolese, MD

Monica Morrow, MD

C Kent Osborne, MD

Sir Richard Peto, FRS

Kathy I. Pritchard, MD

John F. Robertson, MD,FRCS

Andrew D. Seidman, MD

George W. Sledge, MD

Home · Contact us

Terms of use and general disclaimer